Committee for Orphan Medicinal Products (COMP): 4-5 September 2012
Date:
04/09/2012 to 05/09/2012
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes - COMP meeting on 4-5 September 2012 (PDF/248.1 KB)
Adopted
First published: 25/10/2012
Last updated: 25/10/2012
EMA/COMP/471400/2012 -
List item
COMP meeting report on the review of applications for orphan designation: September 2012 (PDF/140.9 KB)
First published: 13/09/2012
Last updated: 13/09/2012
EMA/COMP/548701/2012